Research Roundup

Debbie Rigby 14/10/2025

Debbie Rigby rounds up the latest in research news Budesonide–formoterol versus salbutamol as reliever therapy in children with mild asthma (CARE) In children aged 5–15 years with mild asthma, budesonide–formoterol 50/3 reliever monotherapy as needed is superior to salbutamol reliever monotherapy for preventing asthma attacks, with a similar safety profile. The rate of asthma attacks

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

This web site is intended for Australian pharmacy professionals and is not a substitute for independent professional advice. Information and interactions contained in this website are for information purposes only and are not intended to be used to diagnose, treat, cure or prevent any disease. Further the accuracy, currency and completeness of the information available on this web site cannot be guaranteed. APPco Pty Ltd, its affiliates and their respective servants and agents do not accept any liability for any injury, loss or damage incurred by use of or reliance on the information made available via or through ajp.com.au whether arising from negligence or otherwise.

Research Roundup

Previous Women in pharmacy face systemic and structural challenges

Next Medicinal cannabis system exploited, say Guild, AMA

MENU

ajp.com.au

Previous Women in pharmacy face systemic and structural challenges

Next Medicinal cannabis system exploited, say Guild, AMA

MENU

ajp.com.au

Tags

Hi there! 👋 Looks like you’re not logged in.